Sequencing targeted therapies in CLL after intolerance versus progression
2 years ago
[{"url":"https://i.ytimg.com/vi/ZVyf2SC4vH4/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLBeiZlNMgkrJSu7DE5l2PlONGwksA","width":360,"height":202},{"url":"https://i.ytimg.com/vi/ZVyf2SC4vH4/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLASQn4-5LXWcp_gIpov3j-deVXf3Q","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/ZVyf2SC4vH4/mqdefault_6s.webp?du=3000&sqp=CIS0sKkG&rs=AOn4CLBVx31RE_1_MCf1u68bUc0Srizihw","width":320,"height":180}
[{"text":"Jacqueline Barrientos, MD, MS, Feinstein Institute for Medical Research, Manhasset, NY, shares her views on the sequencing of\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Sequencing targeted therapies in CLL after intolerance versus progression by VJHemOnc \u2013 Video Journal of Hematological Oncology 62 views 2 years ago 5 minutes, 51 seconds","duration":"5 minutes, 51 seconds"}